Finance News – Liver Disease

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Shares Stocks Investors Stock Tariffs Ceo Stock Market Crypto Assets Ethereum Cryptocurrency Price Markets Xrp Eth Etf Ipo Bse Earnings Stablecoin Investment Blockchain Revenue Solana Inflation Index Sec Trade Interest Rates Federal Reserve Wall Street Token Coinbase Treasury Sensex Nasdaq Traders Profit Nse Nifty Sp 500 China Bse Sensex Investor Gold Tesla Company Monetary Policy Trading Bots Policy Decisions Afc Renewable Capacity Ventura Securities National Parking Enforcement Interwork Alliance Ionet Harris Douglas Asset Management Novo

Filter by:

Liver Disease ×

CNBC Business • Aug 18, 2025

Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease

The U.S. authorization of Novo Nordisk’s new therapy for a serious liver condition is expected to positively influence the company’s revenue and market position within the pharmace...

Read Full Article →

Investopedia • Aug 18, 2025

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

The approval of Novo Nordisk's medication for liver disease may positively impact the company’s revenue by expanding its market beyond its current use for weight management.

Read Full Article →